Aksha Chandra Maharaj is a Manteca, California based nurse practitioner. Active license number of Aksha Chandra Maharaj is 95019684 for Family in California. Her current practice location is 332 Northgate Dr, Manteca. Patients can reach her at 209-422-3548 and her NPI number (Unique professional ID assigned by NPPES) is 1265997035. Aksha Chandra Maharaj has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Aksha Chandra Maharaj speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1265997035
NPI Enumeration Date:
06 Feb, 2019
NPI Last Update On:
19 May, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Aksha Chandra Maharaj are as mentioned below.
License Number
Specialization
State
Status
95019684
Family
California
Primary
95093964
Registered Nurse
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Aksha Chandra Maharaj 332 Northgate Dr, Manteca, California
Zip:
95336-3139
Patients can reach Aksha Chandra Maharaj at 332 Northgate Dr, Manteca, California or can call to book an appointment on 209-422-3548.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.